Tate Simon 4
4 · Eliem Therapeutics, Inc. · Filed May 22, 2023
Insider Transaction Report
Form 4
Tate Simon
Director
Transactions
- Award
Stock Option (Right To Buy)
2023-05-18+10,000→ 10,000 totalExercise: $3.00Exp: 2033-05-17→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of May 18, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.